Editorial: Biological Therapies and Eating Disorders.
European eating disorders review : the journal of the Eating Disorders Association – December 15, 2024
Source: PubMed
Summary
New biological treatments show promise for eating disorders, from brain stimulation to innovative medications. Advanced therapies like transcranial magnetic stimulation and ketamine target brain circuits affecting mood and appetite. Treatments ranging from olanzapine to microbiome-based approaches offer hope for conditions like anorexia nervosa and binge eating disorder, while personalized biological interventions may improve recovery rates.
Abstract
Blood-based biomarkers and neuroimaging techniques have improved our understanding of the underlying biology of eating disorders (EDs) and have increased our diagnostic portfolio. This editorial accompanies an article collection on novel biological approaches to treat EDs. The collection covers intermittent theta burst stimulation, therapeutic drug monitoring, pharmacological treatments (olanzapine, metreleptin, psychedelics, and anti-inflammatory medications), microbiome-based treatments such as pro- and prebiotics, as well as individually tailored treatment approaches for EDs. Research of brain areas and bodily systems that are related to memory, emotions and immune function will hopefully expand the biological treatment options for people with EDs.